Share on StockTwits

C.R. Bard (NYSE:BCR) CEO Timothy M. Ring sold 10,231 shares of the company’s stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $149.04, for a total value of $1,524,828.24. Following the transaction, the chief executive officer now directly owns 170,233 shares of the company’s stock, valued at approximately $25,371,526. The sale was disclosed in a filing with the SEC, which is available at this link.

C.R. Bard (NYSE:BCR) traded down 0.68% during mid-day trading on Tuesday, hitting $150.49. 491,760 shares of the company’s stock traded hands. C.R. Bard has a one year low of $111.24 and a one year high of $154.16. The stock has a 50-day moving average of $145.1 and a 200-day moving average of $142.. The company has a market cap of $11.232 billion and a price-to-earnings ratio of 15.44.

C.R. Bard (NYSE:BCR) last issued its quarterly earnings data on Thursday, July 24th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.05. The company had revenue of $827.10 million for the quarter, compared to the consensus estimate of $814.58 million. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, analysts predict that C.R. Bard will post $8.31 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Bank of America downgraded shares of C.R. Bard from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of C.R. Bard in a research note on Monday, July 28th. They now have a $156.00 price target on the stock. Finally, analysts at Raymond James reiterated an “outperform” rating on shares of C.R. Bard in a research note on Friday, July 25th. They now have a $170.00 price target on the stock, up previously from $155.00. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $144.25.

C. R. Bard, Inc (NYSE:BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Receive News & Ratings for CR Bard Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CR Bard Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.